Skip to main content
Caplight Logo









Phiome

Phiome

Private
United KingdomHealthcare & Life Scienceshttps://www.phiome.com/

Last Round

Series B

Nov 1, 2019

Total Funding Raised

$56M

Company Overview

Phiome operates in Healthcare & Life Sciences and is based in the United Kingdom. Its latest recorded funding round was a Series B round in November 2019.

Phiome is a biotechnology company that specializes in odour preventative technology using microbiome-smart ingredients for cosmetic and textile applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, D2C Brands

Business Model

B2B

Customer Profile

Data as a Service, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Phiome Comparables

Compare Phiome with similar companies based on industry and business-model similarity.

Phiome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AOBiome Therapeutics Inc.
71%
Arcaea
70%
Beiersdorf
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Phiome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Phiome Investors

Notable investors and investment history

Phiome investors
InvestorRounds
Ezaki Glico Co., Ltd.Series B
Khosla VenturesSeries B
WestRiver GroupSeries B
BOLD Capital PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2019

    $56M round with participation from Khosla Ventures and BOLD Capital Partners.

Book a demo to see all signals

For institutional investors. Book with your work email.

Phiome Filings

Explore SEC and related filing metadata, where available.

Phiome filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Phiome's valuation, stock price, and market status.

Is Phiome a public or private company?

Phiome is a private company.

What is the current stock price of Phiome?

Phiome is a private company, so its shares have no public market price. Caplight tracks Phiome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Phiome worth (valuation)?

Valuation information for Phiome is not publicly available.

Can I buy Phiome stock?

Phiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Phiome's last funding round?

Phiome's most recent funding round was Series B on November 1, 2019.

Who are the main investors in Phiome?

Key investors in Phiome include Ezaki Glico Co., Ltd., Khosla Ventures, WestRiver Group, BOLD Capital Partners.

Will Phiome IPO soon?

No public IPO plans have been announced for Phiome.

How can I track Phiome secondary market activity?

Caplight tracks bids, offers, and trades in Phiome's shares on secondary markets.

Firmographic Details

HeadquartersUnited Kingdom
Year FoundedN/A
Last FundingNov 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?